Loading…
The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry
Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the...
Saved in:
Published in: | International journal of cardiology 2007-07, Vol.119 (2), p.212-219 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3 |
container_end_page | 219 |
container_issue | 2 |
container_start_page | 212 |
container_title | International journal of cardiology |
container_volume | 119 |
creator | Widimsky, Petr Zelizko, Michal Jansky, Petr Tousek, Frantisek Holm, Frantisek Aschermann, Michael |
description | Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy. |
doi_str_mv | 10.1016/j.ijcard.2007.02.036 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70573609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016752730700527X</els_id><sourcerecordid>70573609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</originalsourceid><addsrcrecordid>eNqFUs2O0zAQDoifLQtvgJAvIJBosRMnTjggoWphkVZCgh4QF8sdT6i7qR1sZ1H3tA8CL7dPgrMtqsRl5cPY8vfj8TdZ9pTRGaOserOemTUor2c5pWJG8xktqrvZhNWCT5ko-b1skmBiWuaiOMoehbCmlPKmqR9mR0xwnqc1ufNgsUJiLBiNFvA1iR5V3KCNJESvIv4wGIiymrghgtukg2uJgiEiAeedVX5LwtZqf3NnLIlJ7_rqt8cefTsE4yyxGH85f3599Wcka9O26EeHlQu9iaojcdsfyPNLhBX5gv2w7Ay8TbswdPHG93CNF6obVBzVb3nPPxNziZr0iZKcA3k5_34yP31FfGowNbp9nN1vVRfwyb4eZ4sPJ4v56fTs88dP8_dnUygZi1MGilPMWwDOl60oal5yXZaa5lCrWpQtikpBq7lutIa6LRqdM2gQS2QF6OI4e7GT7b37OWCIcmMCYNcpi24IUtBSFBVtEpDvgOBdCB5b2XuzSc1JRuUYv1zLXfxyjF_SXKb4E-3ZXn9YblAfSPu8E-D5HqACqK71KkUfDri6zqtKiIR7t8Nh-owLg14GMOOEaOMRotTO3PaS_wWgM9Ykz3PcYli7wdv00ZLJkAjy6ziq46RSQWmq34q_3VXuaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70573609</pqid></control><display><type>article</type><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><source>Elsevier</source><creator>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael</creator><creatorcontrib>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael ; on behalf of the CZECH investigators ; CZECH investigators</creatorcontrib><description>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2007.02.036</identifier><identifier>PMID: 17442424</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Acute coronary syndromes ; Acute myocardial infarction ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Angina, Unstable - diagnosis ; Angina, Unstable - epidemiology ; Angina, Unstable - therapy ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular ; Coronary Angiography ; Coronary Artery Bypass ; Coronary artery bypass surgery ; Coronary heart disease ; Czech Republic - epidemiology ; Diseases of the cardiovascular system ; Female ; Heart ; Hospital Mortality ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Incidence ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - diagnosis ; Myocardial Infarction - epidemiology ; Myocardial Infarction - therapy ; Myocarditis. Cardiomyopathies ; Percutaneous coronary intervention ; Pharmacotheraphy ; Platelet Aggregation Inhibitors - therapeutic use ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Registries ; Registry ; Reperfusion ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Thrombolytic Therapy - methods ; Treatment Outcome</subject><ispartof>International journal of cardiology, 2007-07, Vol.119 (2), p.212-219</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2007 Elsevier Ireland Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</citedby><cites>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18826677$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17442424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Widimsky, Petr</creatorcontrib><creatorcontrib>Zelizko, Michal</creatorcontrib><creatorcontrib>Jansky, Petr</creatorcontrib><creatorcontrib>Tousek, Frantisek</creatorcontrib><creatorcontrib>Holm, Frantisek</creatorcontrib><creatorcontrib>Aschermann, Michael</creatorcontrib><creatorcontrib>on behalf of the CZECH investigators</creatorcontrib><creatorcontrib>CZECH investigators</creatorcontrib><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</description><subject>Acute coronary syndromes</subject><subject>Acute myocardial infarction</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angina, Unstable - diagnosis</subject><subject>Angina, Unstable - epidemiology</subject><subject>Angina, Unstable - therapy</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Coronary Angiography</subject><subject>Coronary Artery Bypass</subject><subject>Coronary artery bypass surgery</subject><subject>Coronary heart disease</subject><subject>Czech Republic - epidemiology</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Heart</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Percutaneous coronary intervention</subject><subject>Pharmacotheraphy</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Registries</subject><subject>Registry</subject><subject>Reperfusion</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Thrombolytic Therapy - methods</subject><subject>Treatment Outcome</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFUs2O0zAQDoifLQtvgJAvIJBosRMnTjggoWphkVZCgh4QF8sdT6i7qR1sZ1H3tA8CL7dPgrMtqsRl5cPY8vfj8TdZ9pTRGaOserOemTUor2c5pWJG8xktqrvZhNWCT5ko-b1skmBiWuaiOMoehbCmlPKmqR9mR0xwnqc1ufNgsUJiLBiNFvA1iR5V3KCNJESvIv4wGIiymrghgtukg2uJgiEiAeedVX5LwtZqf3NnLIlJ7_rqt8cefTsE4yyxGH85f3599Wcka9O26EeHlQu9iaojcdsfyPNLhBX5gv2w7Ay8TbswdPHG93CNF6obVBzVb3nPPxNziZr0iZKcA3k5_34yP31FfGowNbp9nN1vVRfwyb4eZ4sPJ4v56fTs88dP8_dnUygZi1MGilPMWwDOl60oal5yXZaa5lCrWpQtikpBq7lutIa6LRqdM2gQS2QF6OI4e7GT7b37OWCIcmMCYNcpi24IUtBSFBVtEpDvgOBdCB5b2XuzSc1JRuUYv1zLXfxyjF_SXKb4E-3ZXn9YblAfSPu8E-D5HqACqK71KkUfDri6zqtKiIR7t8Nh-owLg14GMOOEaOMRotTO3PaS_wWgM9Ykz3PcYli7wdv00ZLJkAjy6ziq46RSQWmq34q_3VXuaw</recordid><startdate>20070710</startdate><enddate>20070710</enddate><creator>Widimsky, Petr</creator><creator>Zelizko, Michal</creator><creator>Jansky, Petr</creator><creator>Tousek, Frantisek</creator><creator>Holm, Frantisek</creator><creator>Aschermann, Michael</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070710</creationdate><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><author>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acute coronary syndromes</topic><topic>Acute myocardial infarction</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angina, Unstable - diagnosis</topic><topic>Angina, Unstable - epidemiology</topic><topic>Angina, Unstable - therapy</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Coronary Angiography</topic><topic>Coronary Artery Bypass</topic><topic>Coronary artery bypass surgery</topic><topic>Coronary heart disease</topic><topic>Czech Republic - epidemiology</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Heart</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Percutaneous coronary intervention</topic><topic>Pharmacotheraphy</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Registries</topic><topic>Registry</topic><topic>Reperfusion</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Thrombolytic Therapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Widimsky, Petr</creatorcontrib><creatorcontrib>Zelizko, Michal</creatorcontrib><creatorcontrib>Jansky, Petr</creatorcontrib><creatorcontrib>Tousek, Frantisek</creatorcontrib><creatorcontrib>Holm, Frantisek</creatorcontrib><creatorcontrib>Aschermann, Michael</creatorcontrib><creatorcontrib>on behalf of the CZECH investigators</creatorcontrib><creatorcontrib>CZECH investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Widimsky, Petr</au><au>Zelizko, Michal</au><au>Jansky, Petr</au><au>Tousek, Frantisek</au><au>Holm, Frantisek</au><au>Aschermann, Michael</au><aucorp>on behalf of the CZECH investigators</aucorp><aucorp>CZECH investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2007-07-10</date><risdate>2007</risdate><volume>119</volume><issue>2</issue><spage>212</spage><epage>219</epage><pages>212-219</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><abstract>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17442424</pmid><doi>10.1016/j.ijcard.2007.02.036</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-5273 |
ispartof | International journal of cardiology, 2007-07, Vol.119 (2), p.212-219 |
issn | 0167-5273 1874-1754 |
language | eng |
recordid | cdi_proquest_miscellaneous_70573609 |
source | Elsevier |
subjects | Acute coronary syndromes Acute myocardial infarction Adrenergic beta-Antagonists - therapeutic use Adult Aged Aged, 80 and over Angina, Unstable - diagnosis Angina, Unstable - epidemiology Angina, Unstable - therapy Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Cardiology. Vascular system Cardiovascular Coronary Angiography Coronary Artery Bypass Coronary artery bypass surgery Coronary heart disease Czech Republic - epidemiology Diseases of the cardiovascular system Female Heart Hospital Mortality Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Incidence Male Medical sciences Middle Aged Myocardial Infarction - diagnosis Myocardial Infarction - epidemiology Myocardial Infarction - therapy Myocarditis. Cardiomyopathies Percutaneous coronary intervention Pharmacotheraphy Platelet Aggregation Inhibitors - therapeutic use Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Registries Registry Reperfusion Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Thrombolytic Therapy - methods Treatment Outcome |
title | The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A26%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20incidence,%20treatment%20strategies%20and%20outcomes%20of%20acute%20coronary%20syndromes%20in%20the%20%E2%80%9Creperfusion%20network%E2%80%9D%20of%20different%20hospital%20types%20in%20the%20Czech%20Republic:%20Results%20of%20the%20Czech%20evaluation%20of%20acute%20coronary%20syndromes%20in%20hospitalized%20patients%20(CZECH)%20registry&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Widimsky,%20Petr&rft.aucorp=on%20behalf%20of%20the%20CZECH%20investigators&rft.date=2007-07-10&rft.volume=119&rft.issue=2&rft.spage=212&rft.epage=219&rft.pages=212-219&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/j.ijcard.2007.02.036&rft_dat=%3Cproquest_cross%3E70573609%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70573609&rft_id=info:pmid/17442424&rfr_iscdi=true |